Debio 1143
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Debio 1143, covering 2016-03-24 to 2023-06-12. Get the full timeline:
Most recent: Clinical Trial Update: Study to Assess Safety and Efficacy of the Second Mitochondrial-derived Activator of Caspases (SMAC) Mimetic Debio 1143 [Phase 1, Phase 2]